Salt Lake City, UT announced today that it is conducting a voluntary nationwide recall of the companyís product sold under the name Prolatisí. Prolatisí is conducting a voluntary recall after being informed by the Food and Drug Administration (FDA) that lab analysis has found Prolatisí to contain Sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male Erectile Dysfunction (ED), making Prolatisí an unapproved drug. The active drug ingredient is not listed on the product label. Product manufactured prior to August 9, 2010 is included in this recall. Prolatisí is sold nationwide in double blister packs and 40 count bottles.

Read More...